Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
letter
. 2005 Jul 19;173(2):132. doi: 10.1503/cmaj.1050103

DKA and thrombosis

Jeff Burzynski 1
PMCID: PMC1174837  PMID: 16027420

Josephine Ho and associates1 report an unfortunate case of a 6-year-old girl with diabetic ketoacidosis (DKA) and thromboembolic stroke. Although the authors do a credible job of describing the diverse causes of pediatric stroke and the controversies surrounding treatment of children, there was little emphasis on the danger of extreme hyperosmolar states and risks of thrombosis. More information about the initial presentation of the patient, with specific reference to the concentration of serum sodium and serum osmolarity, would have been helpful in determining her risks of thrombosis.

Diabetes is associated with a prothrombotic state through a number of mechanisms.2 The mostly adult entity of hyperosmolar nonketotic coma has had various degrees of association with thrombosis,2,3 as has extreme hypernatremia in breast-feeding neonates.4 Recent evidence has also demonstrated that among children with DKA, there is a higher incidence of deep venous thrombosis with femoral central venous lines.5,6 Serum glucose and sodium concentrations and hence effective plasma osmolarity were significantly higher in those patients with blood clots.5

Although there is no direct evidence for its efficacy, our practice has been to use prophylactic anticoagulation in patients with DKA who are in a significant hyperosmolar state, as well as to eliminate the use of femoral catheters in patients with these risk factors. There is significant controversy surrounding the dose of anticoagulant therapy, specifically whether the efficacy of dosages for prophylaxis of deep venous thrombosis outweighs the risks associated with full systemic anticoagulation.7 As with most clinical issues, particularly in pediatric critical illness, this controversy lends itself well to a clinical trial in patients with extreme hyperosmolar states, including those with DKA.

Jeff Burzynski Assistant Professor of Pediatrics Division of Critical Care University of Iowa Iowa City, Iowa

Footnotes

Competing interests: None declared.

References

  • 1.Ho J, Pacaud D, Hill MD, Ross C, Harniwka L, Mah JK. Diabetic ketoacidosis and pediatric stroke. CMAJ 2005;172(3):327-8. [DOI] [PMC free article] [PubMed]
  • 2.Carr ME. Diabetes mellitus: a hypercoagulable state. J Diabetes Complications 2001;15(1):44-54. [DOI] [PubMed]
  • 3.Whelton MJ, Walde D, Havard CWH. Hyperosmolar non-ketotic diabetic coma: with particular reference to vascular complications. BMJ 1971;1(740):85-6. [DOI] [PMC free article] [PubMed]
  • 4.van Amerongen RH, Moretta AC, Gaeta TJ. Severe hypernatremic dehydration and death in a breast-fed infant. Pediatr Emerg Care 2001;17(3):175-80. [DOI] [PubMed]
  • 5.Worly JM, Fortenberry JD, Hansen I, Chambliss CR, Stockwell J. Deep venous thrombosis in children with diabetic ketoacidosis and femoral central venous catheters. Pediatrics 2004;113(1 Pt 1):e57-60. [DOI] [PubMed]
  • 6.Gutierrez JA, Bagatell R, Samson MP, Theodorou AA, Berg RA. Femoral central venous catheter-associated deep venous thrombosis in children with diabetic ketoacidosis. Crit Care Med 2003;31(1):80-3. [DOI] [PubMed]
  • 7.Kian K, Eiger G. Anticoagulant therapy in hyperosmolar non-ketotic diabetic coma [letter]. Diabet Med 2003;20:603. [DOI] [PubMed]

Articles from CMAJ : Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES